The role of laboratory methods in diagnosis and follow-up of patients with tuberculosis

Lesnik Evelina; Ghinda Serghei

Conţinutul numărului revistei

Articolul precedent

Articolul urmator

441

Ultima descărcare din IBN:
2024-03-03 01:25

Căutarea după subiecte
similare conform CZU

616.24-002.5-074 (1)

Pathology of the respiratory system. Complaints of the respiratory organs (798)

SM ISO690:2012

LESNIK, Evelina, GHINDA, Serghei. The role of laboratory methods in diagnosis and follow-up of patients with tuberculosis. In: Arta Medica , 2022, nr. 3(84), pp. 16-24. ISSN 1810-1852. DOI: https://doi.org/10.5281/zenodo.7305543

EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core

Arta Medica

Numărul 3(84) / 2022 / ISSN 1810-1852 /ISSNe 1810-1879

The role of laboratory methods in diagnosis and follow-up of patients with tuberculosis

DOI:https://doi.org/10.5281/zenodo.7305543

CZU: 616.24-002.5-074

Pag. 16-24

Lesnik Evelina¹, Ghinda Serghei²

¹ ”Nicolae Testemițanu” State University of Medicine and Pharmacy,
² Institute of Phtysiopneumology „Chiril Draganiuc”

Disponibil în IBN: 9 noiembrie 2022

Descarcă PDF

Rezumat

Objective. To conduct a literature review regarding the role of laboratory methods in diagnosis and follow-up of patients with tuberculosis for establishing the need for developing new diagnostic techniques and methods. Material and methods. A systematic literature review was conducted through which the electronic sources published in PubMed and HINARI collection of health literature, and printed material searched according to the Universal Decimal Classification (UDC) were evaluated. The results were grouped and systematized according to the level of scientific evidence. Results. Microbiological methods are recommended in all patients with tuberculosis, for diagnosis and follow-up. The most used immune test is the tuberculin skin test. The disorders of the immune are currently evaluated according to the white cell blood count. Immune research could not provide relevant and reproducible biomarkers. Conclusions. Dynamic approach for the research on immune biomarkers in longitudinal studies, on a large number of patients and multianalyte assays, could provide predictive immune biomarkers to be used for the correction of the anti-TB treatment and intensification of immune modulating treatment.

Cuvinte-cheie
microbiology, immunology, tuberculosis, Diagnosis, follow-up

Cerif XML Export

<?xml version='1.0' encoding='utf-8'?>
<CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'>
<cfResPubl>
<cfResPublId>ibn-ResPubl-167030</cfResPublId>
<cfResPublDate>2022-11-09</cfResPublDate>
<cfVol>84</cfVol>
<cfIssue>3</cfIssue>
<cfStartPage>16</cfStartPage>
<cfISSN>1810-1852</cfISSN>
<cfURI>https://ibn.idsi.md/ro/vizualizare_articol/167030</cfURI>
<cfTitle cfLangCode='EN' cfTrans='o'>The role of laboratory methods in diagnosis and follow-up of patients with tuberculosis</cfTitle>
<cfKeyw cfLangCode='EN' cfTrans='o'>microbiology; immunology; tuberculosis; Diagnosis; follow-up</cfKeyw>
<cfAbstr cfLangCode='EN' cfTrans='o'><p>Objective. To conduct a literature review regarding the role of laboratory methods in diagnosis and follow-up of patients with tuberculosis for establishing the need for developing new diagnostic techniques and methods. Material and methods. A systematic literature review was conducted through which the electronic sources published in PubMed and HINARI collection of health literature, and printed material searched according to the Universal Decimal Classification (UDC) were evaluated. The results were grouped and systematized according to the level of scientific evidence. Results. Microbiological methods are recommended in all patients with tuberculosis, for diagnosis and follow-up. The most used immune test is the tuberculin skin test. The disorders of the immune are currently evaluated according to the white cell blood count. Immune research could not provide relevant and reproducible biomarkers. Conclusions. Dynamic approach for the research on immune biomarkers in longitudinal studies, on a large number of patients and multianalyte assays, could provide predictive immune biomarkers to be used for the correction of the anti-TB treatment and intensification of immune modulating treatment.</p></cfAbstr>
<cfResPubl_Class>
<cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId>
<cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId>
<cfStartDate>2022-11-09T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfResPubl_Class>
<cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId>
<cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId>
<cfStartDate>2022-11-09T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfPers_ResPubl>
<cfPersId>ibn-person-43817</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2022-11-09T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-11720</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2022-11-09T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfFedId>
<cfFedIdId>ibn-doi-167030</cfFedIdId>
<cfFedId>10.5281/zenodo.7305543</cfFedId>
<cfStartDate>2022-11-09T24:00:00</cfStartDate>
<cfFedId_Class>
<cfClassId>31d222b4-11e0-434b-b5ae-088119c51189</cfClassId>
<cfClassSchemeId>bccb3266-689d-4740-a039-c96594b4d916</cfClassSchemeId>
</cfFedId_Class>
<cfFedId_Srv>
<cfSrvId>5123451</cfSrvId>
<cfClassId>eda2b2e2-34c5-11e1-b86c-0800200c9a66</cfClassId>
<cfClassSchemeId>5a270628-f593-4ff4-a44a-95660c76e182</cfClassSchemeId>
</cfFedId_Srv>
</cfFedId>
</cfResPubl>
<cfPers>
<cfPersId>ibn-Pers-43817</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-43817-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2022-11-09T24:00:00</cfStartDate>
<cfFamilyNames>Lesnik</cfFamilyNames>
<cfFirstNames>Evelina</cfFirstNames>
<cfFamilyNames>Лесник</cfFamilyNames>
<cfFirstNames>Э.</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-11720</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-11720-3</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2022-11-09T24:00:00</cfStartDate>
<cfFamilyNames>Гинда</cfFamilyNames>
<cfFirstNames>Сергей</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfSrv>
<cfSrvId>5123451</cfSrvId>
<cfName cfLangCode='en' cfTrans='o'>CrossRef DOI prefix service</cfName>
<cfDescr cfLangCode='en' cfTrans='o'>The service of issuing DOI prefixes to publishers</cfDescr>
<cfKeyw cfLangCode='en' cfTrans='o'>persistent identifier; Digital Object Identifier</cfKeyw>
</cfSrv>
</CERIF>